Pulmonary arterial hypertension modeling with synthetic stable thromboxane A2 analogue (U46619) in porcine: dose adjustment and acute hemodynamic reactions. (25th November 2020)
- Record Type:
- Journal Article
- Title:
- Pulmonary arterial hypertension modeling with synthetic stable thromboxane A2 analogue (U46619) in porcine: dose adjustment and acute hemodynamic reactions. (25th November 2020)
- Main Title:
- Pulmonary arterial hypertension modeling with synthetic stable thromboxane A2 analogue (U46619) in porcine: dose adjustment and acute hemodynamic reactions
- Authors:
- Goncharova, N
Andreeva, E
Vakhrushev, A
Condori Leandro, H.I
Murashova, L
Voronin, S
Korobchenko, L
Mitrofanova, L
Moiseeva, O
Mikhaylov, E - Abstract:
- Abstract: Introduction: Survival in PAH is strongly associated with adaptation of the RV to pressure overload. Purpose: To investigate acute hemodynamic reactions during infusion of the stable thromboxane A2 (TXA2) analogue U46619 in a porcine model. Materials and methods: The study comprised 9 male Landrace pigs (32.7±3.8 kg) under GA. After heparinization, PAH was induced by continuous and stepwise increasing infusion of U46619 (10 mg/ml; Tocris, USA) according to a pre-specified protocol. The target mPAP was 40 mmHg. Hemodynamics was assessed, cardiac output (CO) was calculated using the Fick equation before and during U46619 infusion. Results: U46619 infusion at a previously published rate 0.1, 0.2 μg kg –1 min –1 in pig 1 resulted in rapid hemodynamic deterioration. Two-time reduced U46619 dose infusione resulted in a target mPAP but severe mBP drop in 1, 3, 4 pigs and required cathecholamine support. The U46619 dosage was reduced up to ¼ (0.025, 0.05, 0.075, 0.1, 0.12, 0.15, 0.175 μg kg –1 min –1 ). In animals on 1/4 dosage U46619 infusion, heart rate (HR), mBP, mPAP, RAP and PVR reliably increased and BP was stable (Table 1). There was a positive correlation between the mPAP and heart rate (HR) on U46619 infusion (r=0.66; t=2.38; p=0.048) and between CO and mBP (r=0.66; t=2.36; p=0.04). Low CO was associated with high PVR (r=−0.98; t=−14.3; p<0, 001). Positive correlation between PVR and SVR was revealed (r=0.96; p=0.00002). In 3 pigs with severe mBP drop and PAHAbstract: Introduction: Survival in PAH is strongly associated with adaptation of the RV to pressure overload. Purpose: To investigate acute hemodynamic reactions during infusion of the stable thromboxane A2 (TXA2) analogue U46619 in a porcine model. Materials and methods: The study comprised 9 male Landrace pigs (32.7±3.8 kg) under GA. After heparinization, PAH was induced by continuous and stepwise increasing infusion of U46619 (10 mg/ml; Tocris, USA) according to a pre-specified protocol. The target mPAP was 40 mmHg. Hemodynamics was assessed, cardiac output (CO) was calculated using the Fick equation before and during U46619 infusion. Results: U46619 infusion at a previously published rate 0.1, 0.2 μg kg –1 min –1 in pig 1 resulted in rapid hemodynamic deterioration. Two-time reduced U46619 dose infusione resulted in a target mPAP but severe mBP drop in 1, 3, 4 pigs and required cathecholamine support. The U46619 dosage was reduced up to ¼ (0.025, 0.05, 0.075, 0.1, 0.12, 0.15, 0.175 μg kg –1 min –1 ). In animals on 1/4 dosage U46619 infusion, heart rate (HR), mBP, mPAP, RAP and PVR reliably increased and BP was stable (Table 1). There was a positive correlation between the mPAP and heart rate (HR) on U46619 infusion (r=0.66; t=2.38; p=0.048) and between CO and mBP (r=0.66; t=2.36; p=0.04). Low CO was associated with high PVR (r=−0.98; t=−14.3; p<0, 001). Positive correlation between PVR and SVR was revealed (r=0.96; p=0.00002). In 3 pigs with severe mBP drop and PAH right ventricle subendocardial hemorrhage was revealed on autopsy study. Conclusions: High dose U46619 infusion was associated with acute RV decompensation due to pressure overload accompanied with systemic BP drop and low CO. Lower dosages of U46619 infusion were characterized by stable target mean PAP. HR acceleration and mean systemic BP are of compensation mechanisms for cardiac output maintenance in PAH. Funding Acknowledgement: Type of funding source: Public grant(s) – National budget only. Main funding source(s): RFBR grant 18-315-20050 … (more)
- Is Part Of:
- European heart journal. Volume 41:(2020)Supplement 2
- Journal:
- European heart journal
- Issue:
- Volume 41:(2020)Supplement 2
- Issue Display:
- Volume 41, Issue 2 (2020)
- Year:
- 2020
- Volume:
- 41
- Issue:
- 2
- Issue Sort Value:
- 2020-0041-0002-0000
- Page Start:
- Page End:
- Publication Date:
- 2020-11-25
- Subjects:
- Hypertension, Pulmonary Hypertension
Cardiology -- Periodicals
Heart -- Diseases -- Periodicals
616.12005 - Journal URLs:
- http://eurheartj.oxfordjournals.org/ ↗
http://ukcatalogue.oup.com/ ↗ - DOI:
- 10.1093/ehjci/ehaa946.3812 ↗
- Languages:
- English
- ISSNs:
- 0195-668X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3829.717500
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 25490.xml